GENE ONLINE|News &
Opinion
Blog

Cell and Gene Therapy
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
These Pharma Companies Are Laying Off Employees Due to Restructuring
2022-06-30
BioMarin Wins First Gene Therapy Recommendation For Hemophilia A in Europe
2022-06-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends
2022-05-24
What If Our Body’s Power Station Goes Wrong? Gene Therapy May Help
2022-02-15
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
JPM22 Highlights: Cell and Gene Therapies Rise Up
2022-01-11
Novartis Books Gyroscope for $1.5 Billion in Pursuit of Gene Therapy for Blindness
2021-12-23
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
FDA Approves Kite’s CAR-T Therapy for Adult Leukemia
2021-10-04
What Does It Take for a Cell & Gene Therapy Program to Go Commercial?
2021-09-30
Takeda’s Allogeneic Stem Cell Therapy Becomes First of Its Kind to Be Approved in Japan
2021-09-28
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
1 2 3 4
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!